Hester Biosciences Ltd.
| BSE: 524669 | Sector: Health care |
| NSE: HESTERBIO | ISIN Code: INE782E01017 |
| BSE 00:00 | 25 Jan | 1797.80 |
-4.25 (-0.24%) |
OPEN
1778.65 |
HIGH
1811.00 |
LOW
1743.15 |
| NSE 00:00 | 25 Jan | 1794.40 |
-6.05 (-0.34%) |
OPEN
1780.10 |
HIGH
1825.00 |
LOW
1744.95 |
| OPEN | 1778.65 |
| PREVIOUS CLOSE | 1802.05 |
| VOLUME | 254 |
| 52-Week high | 2851.75 |
| 52-Week low | 1730.05 |
| P/E | 49.57 |
| Mkt Cap.(Rs cr) | 1,530 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Hester Biosciences Ltd. (HESTERBIO) - News Sector
-
Torrent Pharma Q3 PAT up 14% to Rs 249 crore riding on India, Brazil
10.45 pm | 25 Jan 2023 | Business Standard
Torrent Pharma's revenues came in at Rs 2,491 crore for the quarter under review. The Ebitda margins were at 29.1 per cent while gross margins were 71...
-
DRL posts strong 77% profit growth to Rs 1,247 cr riding on US, Russia
6.59 pm | 25 Jan 2023 | Business Standard
Firm says sustained focus on improving productivity has also helped boost profits; DRL is now bullish on its biosimilars and hopes to start filing for...
-
Torrent Pharma Q3 net profit up 14% to Rs 283 cr; interim dividend declared
6.26 pm | 25 Jan 2023 | Press Trust of India
Torrent Pharma on Wednesday said its consolidated net profit increased by 14 per cent to Rs 283 crore in the third quarter ended December 31, 2022. T...
-
Cipla Q3 net up 10% to Rs 801 cr, posts highest ever quarterly sales in US
5.44 pm | 25 Jan 2023 | Business Standard
Revenue up 6% to Rs 5,810 cr; firm expects US FDA audit at Goa unit
-
Lupin Digital launches Lyfe, a 24x7 monitoring ecosystem for heart patients
8.35 pm | 24 Jan 2023 | Business Standard
Company aims to onboard one million patients the platform, which aims to help them improve heart health through doctor-connected online and offline mo...
-
Sun Pharma to acquire US-based Concert Pharmaceuticals for $576 million
10.09 pm | 19 Jan 2023 | Business Standard
Deal size could expand to $827 mn if additional milestone-based payments are made
-
Cipla launches diagnostic device, says it will provide results in minutes
11.55 am | 18 Jan 2023 | Business Standard
Cippoint offers parameters to test for cardiac markers, diabetes, infectious diseases, fertility
-
Lupin gets USFDA tentative nod for generic drugs to treat HIV infection
12.14 am | 17 Jan 2023 | Press Trust of India
Pharmaceutical firm Lupin on Monday said it has received tentative approval from the US health regulator to market its generic version of Dolutegravir...
-
Breather for Natco in Novartis cardiac drug case from Delhi High Court
9.33 pm | 15 Jan 2023 | Business Standard
May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week
-
Breather for Natco in Novartis cardiac drug case from Delhi High Court
9.33 pm | 15 Jan 2023 | Business Standard
May open floodgates for Indian drugmakers to launch the generic version of the drug as early as next week
-
RIL, Dr Reddy's Labs: 5 Nifty500 stocks cross 200-DMA, defying weak trend
11.48 am | 10 Jan 2023 | Business Standard
Following a strong close over the 200-DMA set at Rs 2,559, the chart structure of Reliance Industries reveals a "Double Bottom" breakout
-
Mehul Kothari recommends to buy Laurus Labs, RateGain Travel Technologies
7.44 am | 10 Jan 2023 | Business Standard
According to the technical analyst from Anand Rathi, Laurus Labs can rally to Rs 400; while RateGain can jump to Rs 330.
-
F&O Call: Nandish Shah recommends to long Glenmark Pharma futures
8.02 am | 6 Jan 2023 | Business Standard
The derivative analyst from HDFC Securities expects Glenmark Pharma January futues to test Rs 450 on the upside.
-
Pfizer announces 12-week paternity leave policy for its employees
9.09 pm | 5 Jan 2023 | Business Standard
The policy that came into effect on January 1, 2023, gives biological and adoptive fathers the option to take leaves in up to four tranches
-
Granules forges strategic partnership with Greenko ZeroC for Kakinada plant
3.24 pm | 3 Jan 2023 | Business Standard
Under the collaboration, Greenko ZeroC will be supplying carbon free energy and enable green hydrogen along with its various chemical derivatives
-
Stocks to Watch: Elin Electronics, Cipla, Eicher Motors, RIL, Banks, Pharma
8.17 am | 30 Dec 2022 | Business Standard
Stocks to Watch: Elin Electronics to debut today, the stock is likely to list on a quiet note.
-
Stocks to Watch: NTPC, LIC Housing, Alembic Pharma, SIS, Gail, Puravankara
8.03 am | 27 Dec 2022 | Business Standard
Stocks to Watch: In the F&O space, Punjab National Bank (PNB) is the only stock in ban period on Tuesday.
-
Alembic Pharma gets USFDA nod for generic drug to treat breast cancer
5.30 pm | 26 Dec 2022 | Press Trust of India
Alembic Pharmaceuticals on Monday said it has received final approval from the US health regulator for its generic Fulvestrant injection used in treat...
-
Stocks to Watch: Suven Pharma, Telecom, Restaurant, Travel, DLF, Tata Power
8.16 am | 26 Dec 2022 | Business Standard
Stocks to Watch: Shares of restaurant and travel related firms are likely to be in foucs as government ups the ante to keep the new variant of Coivd-1...
-
Pharma stocks upbeat amid Covid-19 scare; Divi's, Lupin can gain up to 10%
12.19 pm | 23 Dec 2022 | Business Standard
Technically, the Nifty Pharma index needs to immediate hurdle at 13,500, for further upside to 14,250.
Quick Links for Hester Biosciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
